anastrozole has been researched along with Cognition Disorders in 10 studies
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This phase III open-label study compared the impact of tamoxifen and AI on verbal episodic memory (Rey auditory verbal learning test-RAVLT) and other cognitive functions (visual memory, psychomotor speed, and executive functions) after 6 and 12 months of treatment in breast cancer patients undergoing adjuvant hormonotherapy." | 5.20 | A phase III randomized multicenter trial evaluating cognition in post-menopausal breast cancer patients receiving adjuvant hormonotherapy. ( Bonneterre, J; Delbeuck, X; Kramar, A; Le Rhun, E; Lefeuvre-Plesse, C; Pasquier, F; Skrobala, E, 2015) |
| " Breast cancer was diagnosed in 2013 and she has been receiving anastrozole treatment for 6 years after local mass excision surgery and radiotherapy." | 3.96 | The Effect of Theracurmin on Cognitive Function in an Older Patient with Chemobrain. ( Dost Gunay, FS; Erken, N; Isik, AT; Soysal, P, 2020) |
| "Androstenedione, the main circulating ovarian hormone present after menopause, has been shown to positively correlate with poor spatial memory in an ovary-intact rodent model of follicular depletion, and to impair spatial memory when administered exogenously to surgically menopausal ovariectomized rats." | 3.81 | Pharmacological blockade of the aromatase enzyme, but not the androgen receptor, reverses androstenedione-induced cognitive impairments in young surgically menopausal rats. ( Acosta, JI; Alderete, TJ; Bimonte-Nelson, HA; Camp, BW; Demers, LM; Koebele, SV; Mennenga, SE; Mousa, AA; Tsang, CW, 2015) |
| "The purpose of this study was to examine and compare the effects of the first 18 months of anastrozole therapy on cognitive function in women with breast cancer." | 3.81 | Patterns of change in cognitive function with anastrozole therapy. ( Ahrendt, GM; Bender, CM; Berga, SL; Brufsky, AM; Casillo, FE; Dailey, MM; Erickson, KI; Gentry, AL; Kratofil, FM; McAuliffe, PF; Merriman, JD; Rosenzweig, MQ; Ryan, CM; Sereika, SM, 2015) |
| ", tamoxifen and anastrozole) on cognitive functioning by comparing 28 postmenopausal women with breast cancer to 37 healthy age-equivalent controls." | 3.76 | Endocrine therapy is associated with low performance on some estrogen-sensitive cognitive tasks in postmenopausal women with breast cancer. ( Crossley, M; Lejbak, L; Vrbancic, M, 2010) |
| "Post-menopausal breast cancer patients scheduled to receive tamoxifen (n=31) or anastrozole (n=14) completed neuropsychological testing around the time of commencement of treatment (T1), and again 5-6 months later (T2)." | 3.75 | Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study. ( Bielajew, C; Collins, B; Mackenzie, J; Stewart, A; Verma, S, 2009) |
| "Endocrine therapy in the setting of breast cancer has undoubtedly advanced clinical outcomes in this disease, but treatment with endocrine therapy is accompanied by a wide spectrum of side effects." | 1.36 | Cognitive changes associated with endocrine therapy for breast cancer. ( Agrawal, K; Mortimer, JE; Onami, S; Pal, SK, 2010) |
| " As a result, the long-term use of anti-oestrogens may have potential consequences for cognition." | 1.32 | The effects of hormone therapy on cognition in breast cancer. ( Fallowfield, L; Howell, T; Jenkins, V; Shilling, V, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erken, N | 1 |
| Dost Gunay, FS | 1 |
| Soysal, P | 1 |
| Isik, AT | 1 |
| Bender, CM | 2 |
| Merriman, JD | 2 |
| Sereika, SM | 2 |
| Gentry, AL | 2 |
| Casillo, FE | 2 |
| Koleck, TA | 1 |
| Rosenzweig, MQ | 2 |
| Brufsky, AM | 2 |
| McAuliffe, P | 1 |
| Zhu, Y | 1 |
| Conley, YP | 1 |
| Mennenga, SE | 1 |
| Koebele, SV | 1 |
| Mousa, AA | 1 |
| Alderete, TJ | 1 |
| Tsang, CW | 1 |
| Acosta, JI | 1 |
| Camp, BW | 1 |
| Demers, LM | 1 |
| Bimonte-Nelson, HA | 1 |
| Ahrendt, GM | 1 |
| Berga, SL | 1 |
| Dailey, MM | 1 |
| Erickson, KI | 1 |
| Kratofil, FM | 1 |
| McAuliffe, PF | 1 |
| Ryan, CM | 1 |
| Le Rhun, E | 1 |
| Delbeuck, X | 1 |
| Lefeuvre-Plesse, C | 1 |
| Kramar, A | 1 |
| Skrobala, E | 1 |
| Pasquier, F | 1 |
| Bonneterre, J | 1 |
| Collins, B | 1 |
| Mackenzie, J | 1 |
| Stewart, A | 1 |
| Bielajew, C | 1 |
| Verma, S | 1 |
| Lejbak, L | 1 |
| Vrbancic, M | 1 |
| Crossley, M | 1 |
| Agrawal, K | 1 |
| Onami, S | 1 |
| Mortimer, JE | 1 |
| Pal, SK | 1 |
| Shilling, V | 2 |
| Jenkins, V | 2 |
| Fallowfield, L | 2 |
| Howell, T | 1 |
| Howell, A | 1 |
| Hutton, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Prospective, Longitudinal Investigation of the Neuropsychological and Psychosocial Effects of Cancer Therapy[NCT00260975] | 112 participants (Actual) | Observational | 2001-06-30 | Completed | |||
| The Relationship Between Biopsychosocial Functioning and Work-Related Cognitive Limitation Among Employed Breast Cancer Survivors: Case Control Study.[NCT02303145] | 187 participants (Actual) | Observational | 2014-09-30 | Completed | |||
| Chemotherapy-Related Changes in Neurocognitive Function and Symptoms in Colorectal Cancer Patients: A Pilot Study[NCT03683004] | 40 participants (Actual) | Observational | 2018-01-22 | Completed | |||
| Treating Verbal Memory Deficits Following Chemotherapy for Breast Cancer[NCT03017560] | 45 participants (Actual) | Interventional | 2015-12-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for anastrozole and Cognition Disorders
| Article | Year |
|---|---|
A phase III randomized multicenter trial evaluating cognition in post-menopausal breast cancer patients receiving adjuvant hormonotherapy.
Topics: Aged; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neo | 2015 |
Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study.
Topics: Affect; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Anxiet | 2004 |
8 other studies available for anastrozole and Cognition Disorders
| Article | Year |
|---|---|
The Effect of Theracurmin on Cognitive Function in an Older Patient with Chemobrain.
Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cognition; Cognition Disorders | 2020 |
Trajectories of Cognitive Function and Associated Phenotypic and Genotypic Factors in Breast Cancer.
Topics: Adult; Age Factors; Aged; Anastrozole; Antineoplastic Agents; Breast Neoplasms; Chemotherapy, Adjuva | 2018 |
Pharmacological blockade of the aromatase enzyme, but not the androgen receptor, reverses androstenedione-induced cognitive impairments in young surgically menopausal rats.
Topics: Anastrozole; Androgen Antagonists; Androstenedione; Animals; Aromatase Inhibitors; Brain; Cognition | 2015 |
Patterns of change in cognitive function with anastrozole therapy.
Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; | 2015 |
Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Case-Control Studies; Cognition Diso | 2009 |
Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Case-Control Studies; Cognition Diso | 2009 |
Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Case-Control Studies; Cognition Diso | 2009 |
Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Case-Control Studies; Cognition Diso | 2009 |
Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Case-Control Studies; Cognition Diso | 2009 |
Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Case-Control Studies; Cognition Diso | 2009 |
Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Case-Control Studies; Cognition Diso | 2009 |
Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Case-Control Studies; Cognition Diso | 2009 |
Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Case-Control Studies; Cognition Diso | 2009 |
Endocrine therapy is associated with low performance on some estrogen-sensitive cognitive tasks in postmenopausal women with breast cancer.
Topics: Aged; Anastrozole; Breast Neoplasms; Case-Control Studies; Cognition Disorders; Estrogen Antagonists | 2010 |
Cognitive changes associated with endocrine therapy for breast cancer.
Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy P | 2010 |
The effects of hormone therapy on cognition in breast cancer.
Topics: Affect; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combin | 2003 |